Amber List

GRALGRAIL, Inc.

Healthcare · Diagnostics & Research · mid-cap ($2.8B)
-35.9%
from rolling 252-day high of $118.84 set 2026-01-22 · 234d ago
Current
$76.23
Decline depth
-35.9%
Decline σ
3.6σ
TFC
2/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since tracking began

$GRAL has been tracked since 2026-03-01. It was down 55.7% from its 52-week high then — now down -35.9%.

It has clawed back 19.8 percentage points off that level. It bottomed 63.8% below that high along the way.

From the 52-week high as of 2026-03-02 to today. Split-adjusted. Observed, not a forecast.

Structural break signals

GRAL qualifies for the Amber List on decline depth.

Decline depth
-35.9%
From rolling 252-day high of $118.84, 234d ago. Past the 30% Amber threshold.
Time-frame continuity
2/5 bearish
Latest bar on five time frames, daily to yearly. Bearish = 2-Down or red 3.
Decline sigma
3.6σ
Drop over the last 20 bars in units of daily volatility (3.06%/day).

The structural read

What price action says about GRAL.

GRAL qualifies for the Amber List on decline depth — down -35.9% from its rolling 252-day high.

Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 2U (red), weekly 2D (red), monthly 1 (red).

Earnings on file: 2026-05-05. Earnings dates don't affect tiering.

Questions about GRAL

What people ask.

Why is GRAL on Broken Stocks?

GRAL qualifies for the Amber List on decline depth. It is down -35.9% from its rolling 252-day high of $118.84, set on 2026-01-22 — 234d ago.

Is GRAL a falling knife?

Not by the strict technical definition. GRAL is down -35.9% from its 52-week high, but that high was set 234d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. GRAL is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.

Is GRAL a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is GRAL trading inside its 52-week range?

At $76.23, GRAL sits 52.1% of the way from its 52-week low ($29.95) to its 52-week high ($118.84). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has GRAL been declining?

The current 35.9% decline accrued over 234d, which annualizes to roughly -56.0% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does GRAL compare to its sector?

There are 267 other Healthcare tickers on Broken Stocks: 147 Red, 81 Amber, 39 Watch, with 27 showing recovering structural signals. Median sector decline is -36.7% — GRAL's decline is shallower than the sector median.

Does GRAL's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-05) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.